AlphaYouHW
Insider selling
Howard W Robin sold $1.2M of Nektar Therapeutics (NKTR) stock
Howard W Robin, President & CEO of Nektar Therapeutics (NKTR), sold 20,000 shares of NKTR stock worth $1.2M, per an SEC Form 4 filed Jun 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 16, 2026, 2 days before it was made public.
NKTR has moved +10.9% since the trade date, from $60.27 to $66.84 (Sep 21, 2026 close).
- Traded
- Jun 16, 2026
- Disclosed
- Jun 18, 2026
- Filing delay
- 2 days
- Price since
- +10.9%
- Role
- President & CEO
- Source
- SEC Form 4
More NKTR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.